Journal ArticleDOI
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.
Franca Fruzzetti,Stefano Lello,Lazzarini,Stefania Fratta,Marisa Orrù,Roberto Sorge,Luigi Minerba,C Ricci,Ar Genazzani,Gian Benedetto Melis,Anna Maria Paoletti +10 more
TLDR
Evaluating body weight and composition during the menstrual cycle and during oral contraception with EE+DRSP maintains the same concentrations in TBW and ECW observed in the FP, likely due to the antimineralocorticoid activity of DRSP, which counteracts the water retention elicited by estrogen.About:
This article is published in Contraception.The article was published on 2007-03-01. It has received 30 citations till now. The article focuses on the topics: Drospirenone & Body water.read more
Citations
More filters
Journal ArticleDOI
Hormonal contraceptives: pharmacology tailored to women's health
Vincenzo De Leo,Maria Concetta Musacchio,Valentina Cappelli,Paola Piomboni,Giuseppe Morgante +4 more
TL;DR: Progress in the provision of new oral contraceptives has improved the risk/benefit ratio, by increasing benefits and reducing risks.
Journal ArticleDOI
Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.
TL;DR: The literature reporting on the effects of female sex hormones on the pharmacokinetics of antidepressants is reviewed to discuss and evaluate the implications of changes in levels of sex hormones throughout life for the treatment of depression.
Journal ArticleDOI
The Impact of Menstrual Cycle Phase on Athletes' Performance: A Narrative Review.
Mikaeli Anne Carmichael,Rebecca L. Thomson,Rebecca L. Thomson,Lisa J. Moran,Thomas P. Wycherley +4 more
TL;DR: The effect of the menstrual cycle on physical performance is being increasingly recognized as a key consideration for women's sport and a critical field for further research as discussed by the authors, and a narrative review explores the findings of studies investigating the effects of menstrual cycle phase on perceived and objectively measured performance in an athletic population.
Journal ArticleDOI
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
TL;DR: Administration of E2V/DNG does not influence lipid and glucose metabolism, while mixed effect are exerted by EE/CMA, both preparations reduce bone metabolism without influencing short-term effect on body composition.
Journal ArticleDOI
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen.
TL;DR: Drospirenone 3 mg/EE 20 mcg 24/4 is a highly effective COC in nonobese women in this open-label uncontrolled study conducted in 50 European centers.
References
More filters
Journal ArticleDOI
Bioelectrical impedance analysis-part II: utilization in clinical practice.
Ursula G. Kyle,Ingvar Bosaeus,Antonio D. De Lorenzo,Paul Deurenberg,Marinos Elia,José Manuel Gómez,Berit L. Heitmann,Luisa Kent-Smith,Jean-Claude Melchior,Matthias Pirlich,Hermann Scharfetter,Annemie M. W. J. Schols,Claude Pichard +12 more
TL;DR: Clinical use of BIA in subjects at extremes of BMI ranges or with abnormal hydration cannot be recommended for routine assessment of patients until further validation has proven for BIA algorithm to be accurate in such conditions.
Journal ArticleDOI
Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons ☆ ☆☆ ★ ★★
TL;DR: In this paper, the authors defined the frequency and reasons for oral contraceptive discontinuation and subsequent contraceptive behavior and concluded that counseling should emphasize the possibility of side effects, stressing the fact that most will be transient, and the need to identify a backup method.
Journal ArticleDOI
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
TL;DR: Based on the biochemical and pharmacodynamic data, drospirenone appears to be a viable alternative to the currently available progestogens.
Journal ArticleDOI
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.
TL;DR: A new progestogen (Drospirenone) with an antimineralocorticoid effect like that of progesterone is described that slightly lowers body weight and blood pressure in a contraceptive formulation together with EE.
Journal ArticleDOI
Single- and multifrequency models for bioelectrical impedance analysis of body water compartments.
TL;DR: The accuracy and precision of seven previously published BIA models for the measurement of change in body water compartmentalization among individuals infused with lactated Ringer solution or administered a diuretic agent are investigated and it is concluded that the multifrequency Cole-Cole model is superior under conditions in which body water compartments is altered from the normal state.